Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Oscar Bertetto Pierfranco Conte Roberto D'Amico Paolo Bruzzi |
| Publication date | October 1, 2008 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |